Alterations of the INK4a/ARF locus in human intracranial germ cell tumors

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2113-2115

  Iwato, Masayuki ^a   Tachibana, Osamu ^a   Tohma, Yasuo ^a   Arakawa, Yasuaki ^a   Nitta, Hisashi ^b   Hasegawa, Mitsuhiro ^a   Yamashita, Junkoh ^a   Hayashi, Yutaka ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b Fukui Prefectural Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; FRAMESHIFT MUTATION; GENE DELETION; GENE LOCUS; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACRANIAL TUMOR; MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CARRIER PROTEINS; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FRAMESHIFT MUTATION; GERMINOMA; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, GERM CELL AND EMBRYONAL; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0034655245     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jellinger, K. Primary germ cell tumors. Acta Neuropathol., 25: 291-306, 1973.
2. Hoffman, H., Otsubo, H., Hendrick, B., Humphreys, R., Drake, J., Becker, L., Greenberg, M., and Jenkin, D. Intracranial germ-cell tumors in children. J. Neurosurg., 74: 545-551, 1991.
3. Araki, C., and Matsumoto, S. Statistical reevaluation of pinealoma and related tumors in Japan. J. Neurosurg., 30: 146-149, 1969.
4. Bjornsson, J., Scheithauer, B. W., Okazaki, H., and Leech, R. W. Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases. J. Neuropathol. Exp. Neurol., 44: 32-46, 1985.
5. Brodeur, G., Howarth, C., Pratt, C., and Caces, J., and Husto, H. O. Malignant germ cell tumors in 57 children and adolescents. Cancer (Phila.), 48: 1890-1898, 1981.
6. Jennings, M. T., Gelman, R., and Hochberg, F. Intracranial germ-cell tumors: natural history and pathogenesis. J. Neurosurg., 63: 155-167, 1985.
7. Iwato, M., Tachibana, O., Tohma, Y., Nitta, H., Hayashi, Y., and Yamashita, J. Molecular analysis for p53 and mdm2 in intracranial germ cell tumors. Acta Neuropathol., 99: 21-25, 2000.
8. Kamb, A., Gruis, N., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S., Stockert, E., Day, R., III, Johnson, B., and Skolnick, M. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
9. Cairns, P., Polascik, T., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J., Buckler, A., Gabrielson, E., Tockman, M., Cho, K., Hedrick, L., Bova, G., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
10. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev., 12: 2984-2991, 1998.
11. INK4A transcript. Cancer Res., 55: 2995-2997, 1995.
12. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S., Katcher, H., Parry, D., Peters, G., and Kamb, A. Complex structure and regulation of the P16 (MTS) locus. Cancer Res., 55: 2988-2994, 1995.
13. Ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 92: 6289-6293, 1995.
14. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9: 3375-3378, 1994.
15. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
16. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723, 1998.
17. Honda, R., and Yasuda, H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53, EMBO J., 18: 22-27, 1999.
18. Kamijo, T., Weber, J., Zambetti, G., Zindy, F., Roussel, M., and Sherr, C. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA, 95: 8292-8297, 1998.
19. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J., 17: 5001-5014, 1998.
20. ARF. Cell, 91: 649-659, 1997.
21. Kamijo, T., Bodner, S., van de Kamp, E., Randle, D. H., and Sherr, C. J. Tumor spectrum in ARF-deficient mice. Cancer Res., 59: 2217-2222, 1999.
22. Hayashi, Y., Ueki, K., Waha, A., Wiestler, O. D., Louis, D. N., and von Deimling, A. Association of EGFR gene amplification and CDKN2 (p16/MTSI) gene deletion in glioblastoma multiforme. Brain Pathol., 7: 871-875, 1997.
23. Jen, J., Harper, J., Bigner, S., Bigner, D., Papadopoulos, N., Markowitz, S., Willson, J., Kinzler, K., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54: 6353-6358, 1994.
24. Sugano, K., Nakashima, Y., Yamaguchi, K., Fukayama, N., Maekawa, M., Ohkura, H., Kakizoe, T., and Sekiya, T. Sensitive detection of loss of heterozygosity in the TP53 gene in pancreatic adenocarcinoma by fluorescence-based single-strand conformation polymorphism analysis using blunt-end DNA fragments. Genes Chromosomes Cancer, 15: 157-164, 1996.
25. Miyakoshi, J., Kitagawa, K., Yamagishi, N., Ohtsu, S., Day, R. S., III, and Takebe, H. Increased radiosensitivity of p16-deleted human glioma cells after transfection with wild-type p16 gene. Jpn. J. Cancer Res., 88: 34-38, 1997.
26. Tada, M., Matsumoto, R., Iggo, R. D., Shirato, H., Sawamura, Y., and Shinohe, Y. Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations. Cancer Res., 58: 1793-1797, 1998.
27. Riou, G., Barrois, M., Prost, S., Terrier, M. J., Theodore, C., and Levine, A. J. The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol. Carcinog., 12: 124-131, 1995.
28. Guillou, L., Estreicher, A., Chaubert, P., Hurlimann, J., Kurt, A-M., Metthez, G., Iggo, R., Gray, A. C., Jichlinski, P., Leisinger, H-J., and Benhattar, J. Germ cell tumors of the testis overexpress wild-type p53. Am. J. Pathol., 149: 1221-1228, 1996.
29. Chaubert, P., Guillou, L., Kurt, A., Bertholet, M., Metthez, G., Leisinger, H., Bosman, F., and Shaw, P. Frequent p16INK4(MTSI) gene inactivation in testicular germ cell tumors. Am. J. Pathol., 151: 859-865, 1997.
30. Hatta, Y., Hirama, T., Takeuchi, S., Lee, E., Pham. E., Miller, C., Strohmeyer, T., Wilczynski, S., Melmed, S., and Koeffler, H. Alterations of the p16(MTSI) gene in testicular, ovarian, and endometrial malignancies. J. Urol., 154: 1954-1957, 1995.
31. Merlo, A., Herman, J., Mao, L., Lee, D., Gabrielson, E., Burger, P., Baylin, S., and Sidransky, D. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTSI in human cancers. Nat. Med., 1: 686-692, 1995.
32. Robertson, K. D., and Jones, P. A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol., 18: 6457-6473, 1998.
33. ARF, Cell, 91: 555-558, 1997.